Literature DB >> 35785987

Epigenetic modifications in metabolic memory: What are the memories, and can we erase them?

Zhuo Chen1, Rama Natarajan1.   

Abstract

Inherent and acquired abnormalities in gene regulation due to the influence of genetics and epigenetics (traits related to environment rather than genetic factors) underlie many diseases including diabetes. Diabetes could lead to multiple complications including retinopathy, nephropathy, and cardiovascular disease that greatly increase morbidity and mortality. Epigenetic changes have also been linked to diabetes-related complications. Genes associated with many pathophysiological features of these vascular complications (e.g., inflammation, fibrosis, and oxidative stress) can be regulated by epigenetic mechanisms involving histone posttranslational modifications, DNA methylation, changes in chromatin structure/remodeling, and noncoding RNAs. Intriguingly, these epigenetic changes triggered during early periods of hyperglycemic exposure and uncontrolled diabetes are not immediately corrected even after restoration of normoglycemia and metabolic balance. This latency in effect across time and conditions is associated with persistent development of complications in diabetes with prior history of poor glycemic control, termed as metabolic memory or legacy effect. Epigenetic modifications are generally reversible and provide a window of therapeutic opportunity to ameliorate cellular dysfunction and mitigate or "erase" metabolic memory. Notably, trained immunity and related epigenetic changes transmitted from hematopoietic stem cells to innate immune cells have also been implicated in metabolic memory. Hence, identification of epigenetic variations at candidate genes, or epigenetic signatures genome-wide by epigenome-wide association studies can aid in prompt diagnosis to prevent progression of complications and identification of much-needed new therapeutic targets. Herein, we provide a review of epigenetics and epigenomics in metabolic memory of diabetic complications covering the current basic research, clinical data, and translational implications.

Entities:  

Keywords:  DNA methylation; diabetic complications; epigenetics; metabolic memory

Mesh:

Year:  2022        PMID: 35785987      PMCID: PMC9359656          DOI: 10.1152/ajpcell.00201.2022

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   5.282


  108 in total

1.  Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Andrew Advani; Qingling Huang; Kerri Thai; Suzanne L Advani; Kathryn E White; Darren J Kelly; Darren A Yuen; Kim A Connelly; Philip A Marsden; Richard E Gilbert
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.

Authors:  Jun Okabe; Christian Orlowski; Aneta Balcerczyk; Chris Tikellis; Merlin C Thomas; Mark E Cooper; Assam El-Osta
Journal:  Circ Res       Date:  2012-03-08       Impact factor: 17.367

Review 3.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

4.  Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.

Authors:  Luciano Pirola; Aneta Balcerczyk; Richard W Tothill; Izhak Haviv; Antony Kaspi; Sebastian Lunke; Mark Ziemann; Tom Karagiannis; Stephen Tonna; Adam Kowalczyk; Bryan Beresford-Smith; Geoff Macintyre; Ma Kelong; Zhang Hongyu; Jingde Zhu; Assam El-Osta
Journal:  Genome Res       Date:  2011-09-02       Impact factor: 9.043

Review 5.  The biogenesis, biology and characterization of circular RNAs.

Authors:  Lasse S Kristensen; Maria S Andersen; Lotte V W Stagsted; Karoline K Ebbesen; Thomas B Hansen; Jørgen Kjems
Journal:  Nat Rev Genet       Date:  2019-08-08       Impact factor: 53.242

6.  Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon.

Authors:  Qing Zhong; Renu A Kowluru
Journal:  J Cell Biochem       Date:  2010-08-15       Impact factor: 4.429

7.  Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments.

Authors:  Stephanie Fanucchi; Ezio T Fok; Emiliano Dalla; Youtaro Shibayama; Kathleen Börner; Erin Y Chang; Stoyan Stoychev; Maxim Imakaev; Dirk Grimm; Kevin C Wang; Guoliang Li; Wing-Kin Sung; Musa M Mhlanga
Journal:  Nat Genet       Date:  2018-12-10       Impact factor: 38.330

8.  Epigenetics and Mitochondrial Stability in the Metabolic Memory Phenomenon Associated with Continued Progression of Diabetic Retinopathy.

Authors:  Renu A Kowluru; Ghulam Mohammad
Journal:  Sci Rep       Date:  2020-04-20       Impact factor: 4.379

9.  Stress-induced RNA-chromatin interactions promote endothelial dysfunction.

Authors:  Riccardo Calandrelli; Lixia Xu; Yingjun Luo; Weixin Wu; Xiaochen Fan; Tri Nguyen; Chien-Ju Chen; Kiran Sriram; Xiaofang Tang; Andrew B Burns; Rama Natarajan; Zhen Bouman Chen; Sheng Zhong
Journal:  Nat Commun       Date:  2020-10-15       Impact factor: 14.919

Review 10.  Gene regulation by long non-coding RNAs and its biological functions.

Authors:  Luisa Statello; Chun-Jie Guo; Ling-Ling Chen; Maite Huarte
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-22       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.